| Company | Date | Position | Consensus β | Price Target β | 1-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
ALGN
Align Tech
|
Oct 29, 2026 | BUY |
Buy
+89.9% avg upside
21 analysts
|
$210.00
40.19% Upside
|
+6.3% | Β· |
|
LH
Labcorp Holdings
|
Oct 29, 2026 | BUY |
Strong Buy
-21.6% avg upside
38 analysts
|
$410.00
13.45% Upside
|
+1.2% | Β· |
|
ICLR
Icon
|
Oct 29, 2026 | HOLD |
Strong Buy
-1.8% avg upside
28 analysts
|
$220.00
4.06% Upside
|
-9.4% | Β· |
|
PGNY
Progyny
|
Oct 15, 2026 | BUY |
Strong Buy
+14.1% avg upside
15 analysts
|
$37.00
26.79% Upside
|
+33.7% | Β· |
|
XRAY
DENTSPLY SIRONA
|
Oct 14, 2026 | HOLD |
Buy
+182.3% avg upside
25 analysts
|
$10.00
4.87% Upside
|
+6.0% | Β· |
|
NVST
Envista Holdings
|
Oct 14, 2026 | BUY |
Buy
+27.4% avg upside
19 analysts
|
$32.00
36.07% Upside
|
+3.9% | Β· |
|
HSIC
Henry Schein
|
Oct 14, 2026 | HOLD |
Buy
+9.6% avg upside
25 analysts
|
$92.00
8.32% Upside
|
-0.7% | Β· |
|
CVS
CVS Health
|
Oct 12, 2026 | BUY |
Strong Buy
+19.6% avg upside
39 analysts
|
$112.00
24.14% Upside
|
+1.7% | Β· |
|
MDLN
Medline
|
Oct 07, 2026 | BUY |
Strong Buy
+43.4% avg upside
27 analysts
|
$43.00
33.85% Upside
|
+10.5% | Β· |
|
ACH
Accendra Health
|
Sep 18, 2026 | HOLD |
Sell
+6789.2% avg upside
17 analysts
|
β | -89.9% | Β· |
|
CAH
Cardinal Health
|
Aug 11, 2026 | BUY |
Strong Buy
-14.3% avg upside
30 analysts
|
$292.00
16.54% Upside
|
+16.1% | Β· |
|
GDRX
GoodRx Holdings
|
Aug 06, 2026 | BUY |
Buy
+270.4% avg upside
28 analysts
|
$5.00
43.29% Upside
|
-6.7% | Β· |
|
MEDP
Medpace Holdings
|
Jul 23, 2026 | HOLD |
Buy
-17.2% avg upside
18 analysts
|
$620.00
4.85% Downside
|
+6.8% | Β· |
|
CERT
Certara
|
Jun 16, 2026 | BUY |
Buy
+21.4% avg upside
23 analysts
|
$8.00
27.42% Downside
|
+82.8% | Β· |
|
DOCS
Doximity
|
May 15, 2026 | BUY |
Buy
+11.3% avg upside
28 analysts
|
$25.00
23.62% Downside
|
+61.7% | Β· |
|
HIMS
Hims & Hers Health
|
Apr 16, 2026 | HOLD |
Buy
+3.1% avg upside
23 analysts
|
β | -36.8% | Β· |
|
WAY
Waystar Holding Corp.
|
Feb 02, 2026 | BUY |
Strong Buy
+35.0% avg upside
30 analysts
|
$43.00
53.66% Upside
|
+6.8% | Β· |
|
IQV
IQVIA Holdings
|
Dec 14, 2025 | BUY |
Strong Buy
-2.5% avg upside
40 analysts
|
$256.00
4.29% Downside
|
+15.2% | Β· |
|
DGX
Quest Diagnostics
|
Oct 22, 2025 | BUY |
Buy
-26.4% avg upside
34 analysts
|
$210.00
16.62% Downside
|
+36.5% | Β· |
|
COR
Cencora
|
Oct 06, 2025 | BUY |
Buy
-2.6% avg upside
45 analysts
|
$361.00
9.15% Upside
|
+4.4% | Β· |
|
MCK
McKesson
|
Oct 06, 2025 | BUY |
Strong Buy
-20.4% avg upside
29 analysts
|
β | +24.8% | Β· |
|
TDOC
Teladoc
|
Jul 30, 2025 | HOLD |
Buy
+241.7% avg upside
38 analysts
|
$7.50
11.91% Downside
|
-11.1% | Β· |
|
VRTX
Vertex Pharmaceuticals
|
Dec 20, 2024 | BUY |
Strong Buy
-20.5% avg upside
62 analysts
|
$542.00
3.10% Downside
|
+14.8% | Β· |
|
DD
DuPont de Nemours
|
Sep 04, 2024 | HOLD |
Strong Buy
+4.7% avg upside
27 analysts
|
β | -3.6% | Β· |
|
TSE:TRX
TRX Gold Corporation
|
Jul 08, 2024 | BUY |
Strong Buy
+150.7% avg upside
4 analysts
|
β | -16.4% | Β· |
|
SONX
Sonendo
|
Jul 11, 2023 | BUY |
Buy
+825.8% avg upside
5 analysts
|
$3.00
134.38% Upside
|
Β· | Β· |
|
MDRX
Veradigm
|
Jun 14, 2023 | BUY |
Buy
+196.2% avg upside
22 analysts
|
$21.50
330.07% Upside
|
-21.6% | Β· |
|
AMWL
American Well
|
Jan 05, 2022 | HOLD |
Hold
+26.3% avg upside
15 analysts
|
$7.50
41.03% Downside
|
-37.7% | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.